Patent · US Active

Methods for treating and/or limiting development of diabetes

US9744232B2 · kind B2 · utility

2Cited by

2References

21Claims

0Family size

Assignee

BIOCRINE AB · SE

Inventors

Per-Olof Berggren · Solna, SE
Shao-Nian Yang · Stockholm, SE

Key dates

Filing date	Jan 14, 2016
Grant date	Aug 29, 2017
Priority date	—
Expiry date	Jan 14, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides methods for identifying candidate compounds for limiting development of and/or treating diabetes, and methods for limiting development of and/or treating diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.